Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GLI family zinc finger 4 (GLI4) encodes a predicted transcription factor that contains zinc finger domains and is thought to regulate nuclear DNA-templated transcription by binding gene promoters in a sequence-specific manner, acting primarily through RNA polymerase II. It is located on chromosome 8. The gene shares similarity with other zinc finger proteins and is annotated in gene and protein databases by multiple aliases. GLI4 is associated in the literature with regulation of gene expression but remains poorly characterized, with no direct links to drug therapies, biomarkers, or targeted safety literature. *Note: The molecular and disease information is fragmentary; there is no authoritative evidence establishing GLI4 as a direct therapeutic target, nor known drugs acting on it. Many listed aliases are redundant or alternative database names rather than distinct protein forms.
None established; no drugs targeting GLI4, so no mechanisms set
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GLI family zinc finger 4 (GLI4).